Nebenwirkungen · Clopidogrel Teva (hydrogen sulphate)
Clopidogrel Teva 75 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 9
HOS-210596 · Präparat HOS-154547
Clopidogrel has been evaluated for safety in more than 44,000 patients who have participated in clinical studies, including over 12,000 patients treated for 1 year or more. Overall, clopidogrel 75 mg/day was comparable to ASA 325 mg/day in CAPRIE regardless of age, gender and race. The clinically relevant adverse reactions observed in the CAPRIE, CURE, CLARITY, COMMIT and ACTIVE-A studies are discussed below. In addition to clinical studies experience, adverse reactions have been spontaneously reported.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-02-29T12:25:00Z · SHA-256 2668df6ec61f9f4f66d3079105d2dc6c533c7c482102d41117d3a9ecab3c3583 · Passage 025c4f37fb20aaa2b1a4914ba17e2ebfbffabbf799974e62b1d463d4c671eb45 · Zeichen 31–539 im Abschnitt